Free Float 91,53 %
Shares Float 12,69 M
Shares Outstanding 13,86 M
ENTHEON BIOMEDICAL CORP
Share · CA29383X1033 · A2QJBZ (XCNQ)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ENTHEON BIOMEDICAL CORP
No Price
Share Float & Liquidity
Company Profile for ENTHEON BIOMEDICAL CORP Share
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Company Data
Name ENTHEON BIOMEDICAL CORP
Company Entheon Biomedical Corp.
Primary Exchange 
CSE LISTED
CSE LISTED
WKN A2QJBZ
ISIN CA29383X1033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Timothy Ko
Country Canada
Currency EUR
Employees 0,0 T
Address 999 West Broadway, V5Z 1K5 Vancouver
IPO Date 2018-05-03
Stock Splits
| Date | Split |
|---|---|
| 01.03.2024 | 1:10 |
| 12.11.2020 | 1:3 |
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | ENBI.CN |
More Shares
Investors who hold ENTHEON BIOMEDICAL CORP also have the following shares in their portfolio:
